Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Alcohol Abuse

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Alcohol Abuse in 39 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Post-traumatic stress disorder (PTSD) is commonly associated with alcohol and substance use disorders (ASUD)."3.11The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD. ( Brown, RT; Coker, A; Doblin, R; Emerson, A; Klaire, SS; Mitchell, JM; Nicholas, CR; Wang, JB; Yazar-Klosinski, B, 2022)
"Given that alcohol use disorder is so often associated with early traumatic experiences, the author is proposing in a current on-going UK-based study that patients with alcohol use disorder who have undergone a medical detoxification from alcohol might benefit from a course of MDMA-assisted psychotherapy."2.58Why MDMA therapy for alcohol use disorder? And why now? ( Sessa, B, 2018)
"Oxytocin therefore has fascinating potential to reverse the corrosive effects of long-term drugs abuse on social behavior and to perhaps inoculate against future vulnerability to addictive disorders."2.48Breaking the loop: oxytocin as a potential treatment for drug addiction. ( Bowen, MT; McGregor, IS, 2012)
" Some studies have found a dose-response relationship, so that increasing levels of abuse are associated with greater risk of hemorrhage."2.42Cerebrovascular complications of alcohol and sympathomimetic drug abuse. ( Bruno, A, 2003)
"The greatest challenge facing the drug abuse prevention field is to get information out to practitioners and communities about the best prevention programs, approaches, and principles of effectiveness."2.41Prevention of alcohol and drug abuse: what works? ( Kumpfer, KL, 2002)
"Besides smoking, alcohol abuse has also been implicated as a renal risk factor."2.41[Adverse renal effects of legal and illicit drugs]. ( Orth, SR, 2002)
" No unexpected adverse events were observed."1.62First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder. ( Brew-Girard, E; Burrows, S; Durant, C; Higbed, L; Nutt, DJ; O'Brien, S; Rickard, J; Rose-Morris, A; Sakal, C; Sessa, B; Titheradge, D; Williams, TM; Wilson, S; Wiseman, C, 2021)
" There have been no serious adverse events related to MDMA, no unexpected physiological responses to the MDMA sessions or changes to blood results or electrocardiograms, measured before and after the 8-week course."1.51First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants. ( Nutt, D; O'Brien, S; Sakal, C; Sessa, B, 2019)
"Twenty-five had complaints related to substance use including ethanol (n = 18), "molly" or "ecstasy" (n = 13), and marijuana (n = 8)."1.48Emergency Department Patient Burden from an Electronic Dance Music Festival. ( Chhabra, N; Gimbar, RP; Thompson, TM; Walla, LM, 2018)
"Further research is needed to study substance use and related problem behavior among immigrant youth controlling for the impact of acculturation and other factors."1.34Former Soviet Union immigrant and native-born adolescents in Israel: substance use and related problem behavior. ( Isralowitz, RE; Reznik, A, 2007)
"Simultaneous polysubstance use (SPU) is a common phenomenon, yet little is known about how various substances are used with one another."1.33Patterns of simultaneous polysubstance use in drug using university students. ( Barrett, SP; Darredeau, C; Pihl, RO, 2006)

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (7.69)18.2507
2000's20 (51.28)29.6817
2010's13 (33.33)24.3611
2020's3 (7.69)2.80

Authors

AuthorsStudies
Sessa, B4
Aday, JS1
O'Brien, S3
Curran, HV1
Measham, F1
Higbed, L2
Nutt, DJ2
Nicholas, CR1
Wang, JB1
Coker, A1
Mitchell, JM1
Klaire, SS1
Yazar-Klosinski, B1
Emerson, A1
Brown, RT1
Doblin, R1
Durant, C1
Sakal, C2
Titheradge, D1
Williams, TM1
Rose-Morris, A1
Brew-Girard, E1
Burrows, S1
Wiseman, C1
Wilson, S1
Rickard, J1
Chhabra, N1
Gimbar, RP1
Walla, LM1
Thompson, TM1
He, L1
Pan, X1
Wang, N1
Yang, J1
Jiang, J1
Luo, Y1
Zhang, X1
Li, X1
Lake, S1
Gaddis, A1
Tupper, KW1
Nosova, E1
DeBeck, K1
Nutt, D1
O'Sullivan, EM1
Kumpfer, KL1
Keyes, KM1
Martins, SS1
Hasin, DS1
Wilkins, C1
Sweetsur, P1
Krebs, TS1
Johansen, PØ1
Jerome, L1
Halpern, JH1
Fernández-Serrano, MJ1
Lozano, O1
Pérez-García, M3
Verdejo-García, A2
van Holst, RJ1
Schilt, T1
Kinner, SA1
George, J1
Johnston, J1
Dunn, M1
Degenhardt, L1
McGregor, IS1
Bowen, MT1
Carmona-Perera, M1
Young, L1
Molina-Fernández, A1
Burucker, J1
Kropp, S1
Chow, C1
Vallance, K1
Stockwell, T1
Macdonald, S1
Martin, G1
Ivsins, A1
Marsh, DC1
Michelow, W1
Roth, E1
Duff, C1
Bruno, A1
Soto, O1
Hedley-Whyte, ET1
Wareing, M1
Fisk, JE1
Murphy, P1
Montgomery, C1
Verdejo-García, AJ1
López-Torrecillas, F1
Aguilar de Arcos, F1
Johanson, CE1
Kilbey, M1
Gatchalian, K1
Tancer, M1
Reay, JL1
Hamilton, C1
Kennedy, DO1
Scholey, AB1
Hopper, JW1
Su, Z1
Looby, AR1
Ryan, ET1
Penetar, DM1
Palmer, CM1
Lukas, SE1
Barrett, SP1
Darredeau, C1
Pihl, RO1
Laurindo da Silva, L1
Parrott, AC1
Isralowitz, RE1
Reznik, A1
Izco, M1
Marchant, I1
Escobedo, I1
Peraile, I1
Delgado, M1
Higuera-Matas, A1
Olias, O1
Ambrosio, E1
O'Shea, E1
Colado, MI1
Richman, J1
Ferber, A1
Yücel, M1
Lubman, DI1
Solowij, N1
Brewer, WJ1
Hooft, PJ1
van de Voorde, HP1
Durst, R1
Rebaudengo-Rosca, P1
Pedersen, W1
Skrondal, A1
Birnbach, DJ1
Orth, SR1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
MDMA-Assisted Therapy 6 to 12 Months After Childbirth for People With Co-occurring Opioid Use and Post Traumatic Stress Disorders[NCT05219175]Phase 215 participants (Anticipated)Interventional2024-01-01Not yet recruiting
Oxytocin in Alcohol Use Disorder: A Novel and Translational Approach[NCT02711189]Phase 10 participants (Actual)Interventional2016-03-08Withdrawn
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

9 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Alcohol Abuse

ArticleYear
Why MDMA therapy for alcohol use disorder? And why now?
    Neuropharmacology, 2018, Volume: 142

    Topics: Alcoholism; Combined Modality Therapy; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine

2018
Prevention of alcohol and drug abuse: what works?
    Substance abuse, 2002, Volume: 23, Issue:3 Suppl

    Topics: Adolescent; Alcoholism; Amphetamine-Related Disorders; Binge Drinking; Cocaine-Related Disorders; Co

2002
Drug-related decrease in neuropsychological functions of abstinent drug users.
    Current drug abuse reviews, 2011, Volume: 4, Issue:1

    Topics: Alcoholism; Amphetamine-Related Disorders; Cannabis; Central Nervous System Stimulants; Cocaine; Coc

2011
Breaking the loop: oxytocin as a potential treatment for drug addiction.
    Hormones and behavior, 2012, Volume: 61, Issue:3

    Topics: Adaptation, Psychological; Alcoholism; Animals; Drug Tolerance; Hallucinogens; Humans; N-Methyl-3,4-

2012
[Levels of evidence in drug therapy for alcohol use disorders and illicit drug use].
    Fortschritte der Neurologie-Psychiatrie, 2012, Volume: 80, Issue:12

    Topics: Alcohol Deterrents; Alcoholism; Amphetamine-Related Disorders; Cocaine-Related Disorders; Combined M

2012
Cerebrovascular complications of alcohol and sympathomimetic drug abuse.
    Current neurology and neuroscience reports, 2003, Volume: 3, Issue:1

    Topics: Alcohol Drinking; Alcoholism; Catecholamines; Cocaine; Humans; N-Methyl-3,4-methylenedioxyamphetamin

2003
Severe aplastic anemia with hot pockets following daily Ecstasy ingestion.
    American journal of hematology, 2008, Volume: 83, Issue:4

    Topics: Adult; Alcoholism; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow; Fatal Outcome; Hematopoiesis

2008
Understanding drug addiction: a neuropsychological perspective.
    The Australian and New Zealand journal of psychiatry, 2007, Volume: 41, Issue:12

    Topics: Adolescent; Adult; Age Factors; Alcoholism; Analgesics, Opioid; Behavior, Addictive; Central Nervous

2007
[Adverse renal effects of legal and illicit drugs].
    Therapeutische Umschau. Revue therapeutique, 2002, Volume: 59, Issue:3

    Topics: Acute Kidney Injury; Adolescent; Adult; Alcoholism; Amphetamines; Anti-Anxiety Agents; Benzodiazepin

2002

Trials

2 trials available for n-methyl-3,4-methylenedioxyamphetamine and Alcohol Abuse

ArticleYear
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD.
    Drug and alcohol dependence, 2022, 04-01, Volume: 233

    Topics: Adult; Alcoholism; Combined Modality Therapy; Ethanol; Humans; N-Methyl-3,4-methylenedioxyamphetamin

2022
Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.
    Drug and alcohol dependence, 2006, Jan-04, Volume: 81, Issue:1

    Topics: Adult; Alcoholism; Amphetamine-Related Disorders; Arousal; Dextroamphetamine; Discrimination Learnin

2006

Other Studies

28 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Alcohol Abuse

ArticleYear
Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA.
    Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:3

    Topics: Affect; Alcohol Drinking; Alcoholism; Cognition; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxya

2022
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.
    Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:4

    Topics: Alcohol Drinking; Alcoholism; Combined Modality Therapy; Drug Monitoring; Female; Hallucinogens; Hum

2021
Emergency Department Patient Burden from an Electronic Dance Music Festival.
    The Journal of emergency medicine, 2018, Volume: 54, Issue:4

    Topics: Adolescent; Adult; Alcoholism; Chicago; Dancing; Drug Overdose; Emergency Medical Services; Emergenc

2018
New types of drug use and risks of drug use among men who have sex with men: a cross-sectional study in Hangzhou, China.
    BMC infectious diseases, 2018, 04-17, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Alcoholism; China; Cross-Sectional Studies; HIV Infections; Homosexuality, Male;

2018
3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) use and transitions to injection drug use among street-involved youth.
    Substance abuse, 2019, Volume: 40, Issue:3

    Topics: Adolescent; Adult; Alcoholism; Amphetamine-Related Disorders; British Columbia; Cocaine-Related Diso

2019
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.
    BMJ case reports, 2019, Jul-15, Volume: 12, Issue:7

    Topics: Adult; Alcohol Deterrents; Alcoholism; Combined Modality Therapy; Drug Administration Schedule; Fema

2019
Dental health of Irish alcohol/drug abuse treatment centre residents.
    Community dental health, 2012, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Alcoholism; Amphetamine-Related Disorders; Beer; Cocaine-Relat

2012
Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Drug and alcohol dependence, 2008, Sep-01, Volume: 97, Issue:1-2

    Topics: Adolescent; Adult; Age Factors; Alcoholism; Amphetamine-Related Disorders; Comorbidity; Diagnosis, D

2008
Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006.
    The New Zealand medical journal, 2008, May-23, Volume: 121, Issue:1274

    Topics: Adult; Alcohol Drinking; Alcoholism; Amphetamine-Related Disorders; Cross-Sectional Studies; Female;

2008
Importance of psychiatric confounding in non-randomized studies of heavy ecstasy users.
    Psychological medicine, 2009, Volume: 39, Issue:5

    Topics: Alcohol Drinking; Alcoholism; Amphetamine-Related Disorders; Bias; Cognition Disorders; Comorbidity;

2009
Impact of severity of drug use on discrete emotions recognition in polysubstance abusers.
    Drug and alcohol dependence, 2010, Jun-01, Volume: 109, Issue:1-3

    Topics: Adolescent; Adult; Alcoholism; Cocaine-Related Disorders; Data Interpretation, Statistical; Educatio

2010
Pills and pints: risky drinking and alcohol-related harms among regular ecstasy users in Australia.
    Drug and alcohol review, 2012, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Alcohol Drinking; Alcoholism; Amphetamine-Related Disorders; Australia; Cross-Sec

2012
Moral decision-making in polysubstance dependent individuals.
    Drug and alcohol dependence, 2012, Dec-01, Volume: 126, Issue:3

    Topics: Adult; Alcoholism; Case-Control Studies; Cocaine-Related Disorders; Decision Making; Heroin Dependen

2012
Sexual identity and drug use harm among high-risk, active substance users.
    Culture, health & sexuality, 2013, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Alcoholism; Bisexuality; British Columbia; Crack Cocaine; Cross-Sectional S

2013
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2003. A 37-year-old man with a history of alcohol and drug abuse and sudden onset of leg weakness.
    The New England journal of medicine, 2003, Oct-23, Volume: 349, Issue:17

    Topics: Adult; Alcoholism; Arthritis, Gouty; Biopsy; Colchicine; Diagnosis, Differential; Gout Suppressants;

2003
Verbal working memory deficits in current and previous users of MDMA.
    Human psychopharmacology, 2004, Volume: 19, Issue:4

    Topics: Adult; Alcoholism; Comprehension; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Mathematics;

2004
Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
    Addictive behaviors, 2005, Volume: 30, Issue:1

    Topics: Adult; Alcoholism; Cocaine-Related Disorders; Cognition Disorders; Female; Humans; Male; Marijuana A

2005
MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:3

    Topics: Adolescent; Adult; Alcoholism; Amphetamine-Related Disorders; Attention; Cocaine-Related Disorders;

2006
Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study.
    Drug and alcohol dependence, 2006, Dec-01, Volume: 85, Issue:3

    Topics: Adult; Alcoholism; Comorbidity; Demography; Diagnostic and Statistical Manual of Mental Disorders; D

2006
Patterns of simultaneous polysubstance use in drug using university students.
    Human psychopharmacology, 2006, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Alcoholism; Cocaine; Ethanol; Female; Humans; Male; Marijuana Abuse; N-Methyl-3,4

2006
[Modalities of drug consumption among male prostitutes].
    Sante publique (Vandoeuvre-les-Nancy, France), 2006, Volume: 18, Issue:2

    Topics: Adult; Alcoholism; Amphetamine-Related Disorders; Attitude to Health; Cocaine-Related Disorders; Eth

2006
Alcohol, ecstasy, Aldous Huxley's 'soma'.
    Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:1

    Topics: Affect; Alcoholism; Amphetamine-Related Disorders; Central Nervous System Depressants; Drug and Narc

2007
Former Soviet Union immigrant and native-born adolescents in Israel: substance use and related problem behavior.
    Journal of ethnicity in substance abuse, 2007, Volume: 6, Issue:1

    Topics: Acculturation; Adolescent; Alcoholism; Amphetamine-Related Disorders; Child; Cross-Cultural Comparis

2007
Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") exhibit increased ethanol consumption and preference.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:3

    Topics: Alcohol Drinking; Alcoholism; Animals; Dopamine; Dopamine Antagonists; Ethanol; Male; Mice; Mice, In

2007
Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): apropos of a fatal accident during car-surfing.
    International journal of legal medicine, 1994, Volume: 106, Issue:6

    Topics: Accidents, Traffic; Adult; Alcoholism; Brain Injuries; Dangerous Behavior; Fatal Outcome; Humans; Ma

1994
[Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Harefuah, 1997, May-01, Volume: 132, Issue:9

    Topics: Adult; Alcoholism; Attention Deficit Disorder with Hyperactivity; Cannabis; Central Nervous System S

1997
Ecstasy and new patterns of drug use: a normal population study.
    Addiction (Abingdon, England), 1999, Volume: 94, Issue:11

    Topics: Adolescent; Alcoholism; Amphetamines; Cannabis; Cohort Studies; Female; Hallucinogens; Heroin; Human

1999
Interactions in anesthesia: anesthetic management of the drug abusing parturient.
    Acta anaesthesiologica Belgica, 2001, Volume: 52, Issue:4

    Topics: Alcoholism; Amphetamine-Related Disorders; Anesthesia, Obstetrical; Cocaine-Related Disorders; Femal

2001